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The article Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU, written by Sohita Dhillon, was originally published Online First without open access. After publication in volume 39, issue 2, page 221--229 Puma Biotechnology, Inc. requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Puma Biotechnology, Inc. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

The original article has been corrected.
